Delivery Order SPE2DB22D9239-SPE2DB25FDK82
- Not listed
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jakafi 10 mg tablets (60-count units). This firm fixed-price delivery order, valued at $12,115.65, was awarded on July 22, 2025, with an ultimate completion date of July 23, 2025. The award carries no set-aside designation and represents a single delivery order issued under DMS Pharmaceutical Group's larger...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $12,115.65 by the Defense Logistics Agency on July 21, 2025, for the supply of Jakafi 10 mg tablets (60-count packages). The contract utilizes a firm fixed-price structure with no set-aside designation and carries an ultimate completion date of July 22, 2025. This delivery order is issued under DMS Pharmaceutical Group's existing single-award...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $12,115.65 for Jakafi 10 mg tablets (60-count units) by the Defense Logistics Agency's Medical Supply Chain on July 21, 2025, with an ultimate completion date of July 22, 2025. This delivery order was issued without a set-aside designation, and performance will take place at the vendor's Park Ridge, Illinois facility. The...
- The Defense Logistics Agency awarded a delivery order valued at $24,293.60 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jakafi 5 mg tablets (60-count units). This firm fixed-price delivery order was awarded on July 18, 2025, with an ultimate completion date of July 21, 2025, and carries no set-aside designation. The award falls under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a delivery order valued at approximately $12.1K to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jakafi 5 mg tablets (60-count units). The contract carries a firm fixed-price structure with no set-aside designation and an ultimate completion date of July 31, 2025. This delivery order was issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order for $10,943.52 under an indefinite delivery contract with the Defense Logistics Agency to supply Jakafi 10 mg tablets. As a woman-owned small business, DMS Pharmaceutical Group will deliver 60 tablets of Jakafi to the Park Ridge, Illinois location of the Defense Logistics Agency Troop Support Medical. The completion date is listed as November 16, 2023. This delivery order was awarded without a set-aside...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $12,115.65 by the Defense Logistics Agency on July 23, 2025, for the supply of Jakafi 10 mg tablets (60-count). This firm fixed-price delivery order, with an ultimate completion date of July 24, 2025, is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, valued at $499,999,999...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $12,146.79 by the Defense Logistics Agency (DLA) on July 21, 2025, for the supply of Jakafi 5 mg tablets (60-count). This firm fixed-price delivery order, with an ultimate completion date of July 22, 2025, carries no set-aside designation, allowing DMS Pharmaceutical Group to compete on an unrestricted basis leveraging its established...
- The U.S. Defense Logistics Agency has awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, to provide the drug Jakafi 20 mg tablet in 60-count packages. The $11,794.12 contract has a completion date of January 24, 2024. DMS Pharmaceutical Group is an experienced federal contractor that holds multiple indefinite delivery contracts with the Defense Logistics Agency to supply a wide range of pharmaceutical and medical...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the supply of Jakafi 10 mg tablets. The $47,371.79 contract has an ultimate completion date of April 24, 2024. DMS Pharmaceutical Group specializes in providing a wide range of branded and generic prescription drugs, over-the-counter medications, biologics, and medical supplies to support the recurring medical...
- SPE2DB22D9239Indefinite Delivery Contract
- SPE2DB22D9239-SPE2DB25FDK82Delivery Order
The Defense Logistics Agency awarded a $60.6 million firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for 60-count bottles of Jakafi 10 mg tablets, with an ultimate completion date of July 31, 2025. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with DLA valued at $500 million through November 2026 under the SPE2DB program, which authorizes the agency to procure a comprehensive range of pharmaceutical items supporting military healthcare facilities worldwide. Jakafi is a prescription medication used in the treatment of myelofibrosis and polycythemia vera. As a key supplier in the federal pharmaceutical supply chain, DMS Pharmaceutical Group distributes branded and generic prescription drugs, biologics, and medical consumables directly to Department of Defense healthcare sites. The company has maintained a robust portfolio of pharmaceutical delivery orders with DLA, leveraging its woman-owned small business status to compete effectively in federal procurement markets while supporting the medical supply needs of military health facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $60.6k | 7/30/25 |